NASDAQ ยท Healthcare ยท Drug Manufacturers - General
Market Cap$28.49B
SectorHealthcare
Industry
Drug Manufacturers - General
52-Week Low$121.05
52-Week High$205.97
CEOChristopher A. Viehbacher
IPO DateSep 17, 1991
Employees7,605
CountryUnited States
Biogen Inc. discovers, develops, manufactures, and delivers therapies for treating neurological and neurodegenerative diseases. The company offers TECFIDERA, VUMERITY, AVONEX, PLEGRIDY, TYSABRI, and FAMPYRA for multiple sclerosis (MS); SPINRAZA for spinal muscular atrophy; and FUMADERM to treat plaque psoriasis.